|
Life Sciences Strategic Planning
The Principals have many decades of experience in the life-science sector as well
as in finance, transaction execution, and emerging-company financial and strategic
advisory services. The life-science experience encompasses drug discovery and product
development; identifying, evaluating, developing, commercializing, and marketing
life-science technologies and products; executive management of life science companies;
and investing in life-science companies. In addition, the Trillium database which contains
comprehensive information on seed-stage, start-up, and other early stage private
companies as well as public companies provides a valuable resource from which alternative,
complementary, and competitive technologies can be systematically compared in the context
of strategic planning. The database is expected to enhance the ability of the Team to
find or create investment opportunities, understand the competitive landscape of each
portfolio company, find successful managers when appropriate, and find complementary
technologies for portfolio companies to license to accelerate their growth. The Trillium
Team will provide the following services in the strategic planning arena:
-
Advise clients on management, focus, and structure of life science NewCo’s
-
Provide technology and product development expertise
-
Sourcing of investment capital
-
Advise clients on licensing/alliance/merger/acquisition and IPO strategies
|
|